Going new places using an old MAP: Tau, microtubules and human neurodegenerative disease

Current Opinion in Cell Biology

Volumn 13, Issue 1, 2001, Pages 41-48

  Garcia, Michael L ^a   Cleveland, Don W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 5; MUTANT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; CHROMOSOME 17; DEGENERATIVE DISEASE; FRONTOTEMPORAL DEMENTIA; HUMAN; INTRON; MICROTUBULE; MISSENSE MUTATION; NERVE FUNCTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; RNA SPLICING;

EID: 0035140975     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00172-1     Document Type: Review

References (51)

1. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
2. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly
3. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons
4. Altered microtubule organization in small-calibre axons of mice lacking tau protein
5. Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene
6. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes
7. Dynamic instability of microtubule growth
8. Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau
9. Mutant genes in familial Alzheimer's disease and transgenic models
10. Pathogenic implications of mutations in the tau gene in pallido-pontonigral degeneration and related neurodegenerative disorders linked to chromosome 17
11. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
12. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
13. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
14. Tau is a candidate gene for chromosome 17 frontotemporal dementia
15. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
16. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
17. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions
18. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
19. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
20. Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation
21. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations
22. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations
23. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure
24. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
25. The tau gene in progressive supranuclear palsy: Exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases
26. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
27. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies
28. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17
29. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
30. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia
31. Determinants of 4-repeat tau expression, coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion
32. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
33. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations
34. Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease
35. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease
36. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
37. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes
38. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
39. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
40. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
41. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
42. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
43. Tau gene mutation K257T causes a tauopathy similar to Pick's Disease
44. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
45. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
46. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
47. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene
48. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits
49. A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: Clinical and pathological features
50. A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
51. Tau gene mutation in familial progressive subcortical gliosis